154 related articles for article (PubMed ID: 25528574)
1. Statistical analysis plan for the Erythropoietin in Traumatic Brain Injury trial: a randomised controlled trial of erythropoietin versus placebo in moderate and severe traumatic brain injury.
Presneill J; Little L; Nichol A; French C; Cooper DJ; Haddad S; Duranteau J; Huet O; Skrifvars M; Arabi Y; Bellomo R; ;
Trials; 2014 Dec; 15():501. PubMed ID: 25528574
[TBL] [Abstract][Full Text] [Related]
2. Statistical analysis plan for the POLAR-RCT: The Prophylactic hypOthermia trial to Lessen trAumatic bRain injury-Randomised Controlled Trial.
Presneill J; Gantner D; Nichol A; McArthur C; Forbes A; Kasza J; Trapani T; Murray L; Bernard S; Cameron P; Capellier G; Huet O; Newby L; Rashford S; Rosenfeld JV; Smith T; Stephenson M; Varma D; Vallance S; Walker T; Webb S; James Cooper D;
Trials; 2018 Apr; 19(1):259. PubMed ID: 29703266
[TBL] [Abstract][Full Text] [Related]
3. Erythropoietin in traumatic brain injury: study protocol for a randomised controlled trial.
Nichol A; French C; Little L; Presneill J; Cooper DJ; Haddad S; Duranteau J; Huet O; Skrifvars M; Arabi Y; Bellomo R;
Trials; 2015 Feb; 16():39. PubMed ID: 25884605
[TBL] [Abstract][Full Text] [Related]
4. Erythropoietin in traumatic brain injury (EPO-TBI): a double-blind randomised controlled trial.
Nichol A; French C; Little L; Haddad S; Presneill J; Arabi Y; Bailey M; Cooper DJ; Duranteau J; Huet O; Mak A; McArthur C; Pettilä V; Skrifvars M; Vallance S; Varma D; Wills J; Bellomo R; ;
Lancet; 2015 Dec; 386(10012):2499-506. PubMed ID: 26452709
[TBL] [Abstract][Full Text] [Related]
5. Cost-Effectiveness of Erythropoietin in Traumatic Brain Injury: A Multinational Trial-Based Economic Analysis.
Knott RJ; Harris A; Higgins A; Nichol A; French C; Little L; Haddad S; Presneill J; Arabi Y; Bailey M; Cooper DJ; Duranteau J; Huet O; Mak A; McArthur C; Pettilä V; Skrifvars MB; Vallance S; Varma D; Wills J; Bellomo R
J Neurotrauma; 2019 Sep; 36(17):2541-2548. PubMed ID: 30907230
[TBL] [Abstract][Full Text] [Related]
6. Progesterone for acute traumatic brain injury.
Ma J; Huang S; Qin S; You C; Zeng Y
Cochrane Database Syst Rev; 2016 Dec; 12(12):CD008409. PubMed ID: 28005271
[TBL] [Abstract][Full Text] [Related]
7. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of dexanabinol in severe traumatic brain injury: results of a phase III randomised, placebo-controlled, clinical trial.
Maas AI; Murray G; Henney H; Kassem N; Legrand V; Mangelus M; Muizelaar JP; Stocchetti N; Knoller N;
Lancet Neurol; 2006 Jan; 5(1):38-45. PubMed ID: 16361021
[TBL] [Abstract][Full Text] [Related]
9. Statistical analysis plan for the EuroHYP-1 trial: European multicentre, randomised, phase III clinical trial of the therapeutic hypothermia plus best medical treatment versus best medical treatment alone for acute ischaemic stroke.
Winkel P; Bath PM; Gluud C; Lindschou J; van der Worp HB; Macleod MR; Szabo I; Durand-Zaleski I; Schwab S;
Trials; 2017 Nov; 18(1):573. PubMed ID: 29187242
[TBL] [Abstract][Full Text] [Related]
10. The citicoline brain injury treatment (COBRIT) trial: design and methods.
Zafonte R; Friedewald WT; Lee SM; Levin B; Diaz-Arrastia R; Ansel B; Eisenberg H; Timmons SD; Temkin N; Novack T; Ricker J; Merchant R; Jallo J
J Neurotrauma; 2009 Dec; 26(12):2207-16. PubMed ID: 19803786
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic hypothermia to reduce intracranial pressure after traumatic brain injury: the Eurotherm3235 RCT.
Andrews PJ; Sinclair HL; Rodríguez A; Harris B; Rhodes J; Watson H; Murray G
Health Technol Assess; 2018 Aug; 22(45):1-134. PubMed ID: 30168413
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of Ronopterin (VAS203) in Patients with Moderate and Severe Traumatic Brain Injury (NOSTRA phase III trial): study protocol of a confirmatory, placebo-controlled, randomised, double blind, multi-centre study.
Tegtmeier F; Schinzel R; Beer R; Bulters D; LeFrant JY; Sahuquillo J; Unterberg A; Andrews P; Belli A; Ibanez J; Lagares A; Mokry M; Willschke H; Flüh C; Schmutzhard E;
Trials; 2020 Jan; 21(1):80. PubMed ID: 31937347
[TBL] [Abstract][Full Text] [Related]
13. Tranexamic acid to reduce head injury death in people with traumatic brain injury: the CRASH-3 international RCT.
Roberts I; Shakur-Still H; Aeron-Thomas A; Beaumont D; Belli A; Brenner A; Cargill M; Chaudhri R; Douglas N; Frimley L; Gilliam C; Geer A; Jamal Z; Jooma R; Mansukhani R; Miners A; Pott J; Prowse D; Shokunbi T; Williams J
Health Technol Assess; 2021 Apr; 25(26):1-76. PubMed ID: 33928903
[TBL] [Abstract][Full Text] [Related]
14. Association Between Early External Ventricular Drain Insertion and Functional Outcomes 6 Months Following Moderate-to-Severe Traumatic Brain Injury.
Taylor JD; Bailey M; Cooper DJ; French C; Menon DK; Nichol AD; Pisică D; Udy A; Volovici V; Higgins AM
J Neurotrauma; 2024 Jun; 41(11-12):1364-1374. PubMed ID: 38279804
[TBL] [Abstract][Full Text] [Related]
15. Right median nerve electrical stimulation for acute traumatic coma (the Asia Coma Electrical Stimulation trial): study protocol for a randomised controlled trial.
Wu X; Zhang C; Feng J; Mao Q; Gao G; Jiang J
Trials; 2017 Jul; 18(1):311. PubMed ID: 28693604
[TBL] [Abstract][Full Text] [Related]
16. The effect of recombinant erythropoietin on long-term outcome after moderate-to-severe traumatic brain injury.
Skrifvars MB; Luethi N; Bailey M; French C; Nichol A; Trapani T; McArthur C; Arabi YM; Bendel S; Cooper DJ; Bellomo R;
Intensive Care Med; 2023 Jul; 49(7):831-839. PubMed ID: 37405413
[TBL] [Abstract][Full Text] [Related]
17. Risk Adjustment In Neurocritical care (RAIN)--prospective validation of risk prediction models for adult patients with acute traumatic brain injury to use to evaluate the optimum location and comparative costs of neurocritical care: a cohort study.
Harrison DA; Prabhu G; Grieve R; Harvey SE; Sadique MZ; Gomes M; Griggs KA; Walmsley E; Smith M; Yeoman P; Lecky FE; Hutchinson PJ; Menon DK; Rowan KM
Health Technol Assess; 2013 Jun; 17(23):vii-viii, 1-350. PubMed ID: 23763763
[TBL] [Abstract][Full Text] [Related]
18. Improved outcomes from the administration of progesterone for patients with acute severe traumatic brain injury: a randomized controlled trial.
Xiao G; Wei J; Yan W; Wang W; Lu Z
Crit Care; 2008; 12(2):R61. PubMed ID: 18447940
[TBL] [Abstract][Full Text] [Related]
19. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
[TBL] [Abstract][Full Text] [Related]
20. Delayed administration of erythropoietin reducing hippocampal cell loss, enhancing angiogenesis and neurogenesis, and improving functional outcome following traumatic brain injury in rats: comparison of treatment with single and triple dose.
Xiong Y; Mahmood A; Meng Y; Zhang Y; Qu C; Schallert T; Chopp M
J Neurosurg; 2010 Sep; 113(3):598-608. PubMed ID: 19817538
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
